Beryl Drugs Share Price

BSE
19.56
+0.42 (0.00%)
BERLDRG • 13 Jun, 2025 | 03:24 PM
BUY

1Y Annualised Return

-46.61%

3Y Annualised Return

27.53%

5Y Annualised Return

27.37%

The current prices are delayed, login or Open Demat Account for live prices.

Beryl Drugs SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹51,89,812 (-20.16%)

Daily SIP of 25,000 would have become 51,89,812 in 1 year with a gain of -13,10,187 (-20.16%)

Beryl Drugs Stock Performance
Today’s Low - High
18.20
20.09
18.20
20.09
52 Week Low - High
17.35
46.00
17.35
46.00

Open

18.20

Prev. Close

19.14

Volume

19,295.00

Total Traded Value

3.86 L

View details of Market Depth
Beryl Drugs Fundamental

Market Cap (in crs)

10.13

Face Value

10

Turnover (in lacs)

3.86

Key Metrics
Qtr Change %
56.57% Fall from 52W High
-19.2
Dividend yield 1yr %
0

Beryl Drugs Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Beryl Drugs Quarterly Revenue

Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017
4.73 Cr
3.63 Cr
3.24 Cr
4.88 Cr
2.51 Cr

Beryl Drugs Yearly Revenue

Mar 2018Mar 2017
15.99 Cr
11.53 Cr

Beryl Drugs Quarterly Net Profit/Loss

Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017
0.88 Cr
0.1 Cr
0.09 Cr
0.03 Cr
-0.02 Cr

Beryl Drugs Yearly Net Profit/Loss

Mar 2018Mar 2017
0.99 Cr
-0.41 Cr

Beryl Drugs shareholding Pattern

Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%

Beryl Drugs Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
19.56
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
19.50
10Day EMA
19.40
12Day EMA
19.40
20Day EMA
19.50
26Day EMA
19.60
50Day EMA
20.90
100Day EMA
24.00
200Day EMA
27.30
5Day SMA
19.40
10Day SMA
19.30
20Day SMA
19.30
30Day SMA
19.20
50Day SMA
20.40
100Day SMA
24.80
150Day SMA
28.50
200Day SMA
30.70
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
19295 Rs
19295 Rs
Week Rs
7527 Rs
7527 Rs
Month Rs
3101 Rs
3101 Rs
Resistance & Support
19.42
Pivot
Resistance
First Resistance
20.65
Second Resistance
21.31
Third Resistance
22.54
Support
First Support
18.76
Second support
17.53
Third Support
16.87
Relative Strength Index
52.63
Money Flow Index
67.74
MACD
-0.28
MACD Signal
-0.46
Average True Range
1.10
Average Directional Index
14.33
Rate of Change (21)
2.20
Rate of Change (125)
-41.87

Beryl Drugs Latest News

31 MAY 2025 | Saturday

Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Newspaper Publication

30 MAY 2025 | Friday

Beryl Drugs Ltd - 524606 - AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2025

30 MAY 2025 | Friday

Beryl Drugs Ltd - 524606 - Board Meeting Outcome for OUTCOME OF BOARD MEETING

View More

Beryl Drugs Company background

Founded in: 1993
Managing director: Sanjay Sethi
Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERICEF injection, FNeuron, Amplicillin INJ, PMol, Biprox, BFlox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.

As of 13 Jun, 2025, BERLDRG share price is ₹20. The stock opened at ₹18.2 and had closed at ₹19.1 the previous day. During today’s trading session, BERLDRG share price moved between ₹18.20 and ₹20.09, with an average price for the day of ₹19.00. Over the last 52 weeks, the stock has recorded a low of ₹17.35 and a high of ₹46.00. In terms of performance, BERLDRG share price has declined by 47.4% over the past six months and has declined by 46.61% over the last year.

Read More

Beryl Drugs FAQs

You can easily buy Beryl Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Beryl Drugs stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -